The FDA classified BPC-157 as a Category 2 bulk drug substance in 2023, meaning it cannot be compounded by commercial pharmaceutical companies and there is insufficient evidence regarding potential human harm
The compound affects both fat metabolism and muscle health, so its useful for researchers studying the relationship between these systems
Microbial inhibition The 0.9% benzyl alcohol content inhibits the growth of bacteria, fungi, and other microorganisms that could contaminate reconstituted solutions upon repeated vial access
Here is a vial reconstitution protocol, a step-by-step guide with example
Those who want to balance hormones and immune health naturally
Southern Care Anesthetics strictly adheres to all federal and state regulations, which means that any discussion or consideration of BPC-157 would be within legal and ethical boundariesanother factor influencing cost and access